ArticleFrontiers in medicine2025
Epidemiological trends and age-period-cohort effects on subarachnoid hemorrhage burden across the BRICS-plus from 1992 to 2021.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Subarachnoid hemorrhage (SAH) is a major global health concern associated with disproportionately high morbidity and mortality. The BRICS-plus nations (Brazil, Russian Federation, India, China, South Africa, and six other new members), account for a substantial proportion of the global population while being confronted with distinct public health challenges. This study aims to examine epidemiological trends and regional variations in SAH burden across BRICS-plus nations through comprehensive and timely analysis. Methods: Data on the number, all-age rate, age-standardized rate, and relative change in SAH incidence from 1992 to 2021 across eleven BRICS-plus members were sourced from the Global Burden of Disease Study (GBD) 2021. Associations between the incidence rate and the Socio-demographic Index (SDI) were assessed through Pearson correlation analyses. Furthermore, age-period-cohort modeling was utilized to quantify net drift, local drift, age, period, and cohort effects over the past three decades. Results: Except for China, SAH cases were observed to have significantly increased in the other ten BRICS members from 1992 to 2021. All BRICS-plus countries exhibited a declining trend in the age-standardized incidence rate over the study period. Indonesia reported the highest age-standardized incidence rate (10.94 per 100,000 population) in 2021, while China displayed the most significant decrease, at 59.36%. The annual net drift in the SAH incidence rate ranged from -3.36%% for China to -0.50% for the Russian Federation among the eleven countries. A significant negative correlation was observed between the incidence rate of SAH and SDI values. Nations displayed similar age-effect patterns characterized by initial declines followed by subsequent increases with advancing age, along with distinct period and cohort effects that may reflect variations in control measures and temporal burden patterns. Conclusion: Our study demonstrates the overall decline in age standardized incidence rate of SAH, while highlighting the persistent health inequalities among eleven countries potentially attributable to socioeconomic disparities. Furthermore, the findings underscore the imperative for tailored interventions across age, period, and cohort dimensions to mitigate SAH-specific challenges in nations undergoing rapid development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.